Our vision is to help increase cancer survival rate by 30% by 2030 and co-create the future of fighting cancer as well as other serious chronic diseases. We are first ever European based cutting-edge medical DeepTech connecting molecular biology with novel photonics technologies, chemistry & biomedical engineering. We create solutions that can revolutionize healthcare worldwide, incl. the first ever In Vivo Photonics Immunoassays platform - inPROBE® technology. We are merging competences of scientists and experts from many different scientific and business fields.
| Website | http://www.sdsoptic.com |
| Revenue | $5.1 million |
| Employees | 19 (14 on RocketReach) |
| Founded | 2013 |
| Industry | Biotechnology Research, Biotechnology, Science and Engineering, Medical, Health Care, Medical Device |
| Keywords | Medical Technology, Deeptech, Molecular Biology, Cancer Diagnostics, Biotechnology, Health Tech, Cancer Research, Life Sciences, Molecular Diagnostics, Disease Diagnostics, Diagnostic Tools, Precision Medicine, Digital Health, Biomedical Engineering, Clinical Diagnostics, Medical Devices, Pharmaceutical Technology, Drug Discovery, Therapeutic Solutions, Medical Imaging |
| Competitors | Thorlabs, Edmund Optics, Zygo, Vision Engineering Ltd, Photonics Media, TeraXion, Micron Optics, Inc., NTT Electronics, Optovia, Lumerical Solutions, Inc +31 more (view full list) |
Looking for a particular SDS Optic Inc. employee's phone or email?
The SDS Optic Inc. annual revenue was $5.1 million in 2026.
Marcin Staniszewski is the Prezes zarządu | CEO of SDS Optic Inc..
14 people are employed at SDS Optic Inc..